Global Targeted Delivery Drugs Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI09243054

Publication Date:

September 24, 2024

Pages:

111

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Targeted Delivery Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Targeted Delivery Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Targeted Delivery Drugs market. Targeted Delivery Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Targeted Delivery Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Targeted Delivery Drugs market.
Targeted delivery of drugs is defined as a method of injecting drugs into the body so that they only target specific parts of the body. Targeted delivery of drugs is designed to target, extend and protect interactions with diseased tissues.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Targeted Delivery Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Targeted Delivery Drugs market. It may include historical data, market segmentation by Type (e.g., Ocular Drug Delivery, Pulmonary Drug Delivery), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Targeted Delivery Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Targeted Delivery Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Targeted Delivery Drugs industry. This include advancements in Targeted Delivery Drugs technology, Targeted Delivery Drugs new entrants, Targeted Delivery Drugs new investment, and other innovations that are shaping the future of Targeted Delivery Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Targeted Delivery Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Targeted Delivery Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Targeted Delivery Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Targeted Delivery Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Targeted Delivery Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Targeted Delivery Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Targeted Delivery Drugs market.
Market Segmentation:
Targeted Delivery Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Ocular Drug Delivery
Pulmonary Drug Delivery
Drug Eluting Stents
Other
Segmentation by application
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Adverum
Arrowhead Pharmaceuticals
Bayer
Windtree Therapeutics
Immunocore
Mankind Pharma
Roche
Ra Pharma
Keystone Nano
Lipocine
MultiVir

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Targeted Delivery Drugs Market Size 2019-2030
2.1.2 Targeted Delivery Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Targeted Delivery Drugs Segment by Type
2.2.1 Ocular Drug Delivery
2.2.2 Pulmonary Drug Delivery
2.2.3 Drug Eluting Stents
2.2.4 Other
2.3 Targeted Delivery Drugs Market Size by Type
2.3.1 Targeted Delivery Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Targeted Delivery Drugs Market Size Market Share by Type (2019-2024)
2.4 Targeted Delivery Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Targeted Delivery Drugs Market Size by Application
2.5.1 Targeted Delivery Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Targeted Delivery Drugs Market Size Market Share by Application (2019-2024)
3 Targeted Delivery Drugs Market Size by Player
3.1 Targeted Delivery Drugs Market Size Market Share by Players
3.1.1 Global Targeted Delivery Drugs Revenue by Players (2019-2024)
3.1.2 Global Targeted Delivery Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Targeted Delivery Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Targeted Delivery Drugs by Regions
4.1 Targeted Delivery Drugs Market Size by Regions (2019-2024)
4.2 Americas Targeted Delivery Drugs Market Size Growth (2019-2024)
4.3 APAC Targeted Delivery Drugs Market Size Growth (2019-2024)
4.4 Europe Targeted Delivery Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Targeted Delivery Drugs Market Size Growth (2019-2024)
5 Americas
5.1 Americas Targeted Delivery Drugs Market Size by Country (2019-2024)
5.2 Americas Targeted Delivery Drugs Market Size by Type (2019-2024)
5.3 Americas Targeted Delivery Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Delivery Drugs Market Size by Region (2019-2024)
6.2 APAC Targeted Delivery Drugs Market Size by Type (2019-2024)
6.3 APAC Targeted Delivery Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Targeted Delivery Drugs by Country (2019-2024)
7.2 Europe Targeted Delivery Drugs Market Size by Type (2019-2024)
7.3 Europe Targeted Delivery Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Targeted Delivery Drugs by Region (2019-2024)
8.2 Middle East & Africa Targeted Delivery Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Targeted Delivery Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Targeted Delivery Drugs Market Forecast
10.1 Global Targeted Delivery Drugs Forecast by Regions (2025-2030)
10.1.1 Global Targeted Delivery Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Targeted Delivery Drugs Forecast
10.1.3 APAC Targeted Delivery Drugs Forecast
10.1.4 Europe Targeted Delivery Drugs Forecast
10.1.5 Middle East & Africa Targeted Delivery Drugs Forecast
10.2 Americas Targeted Delivery Drugs Forecast by Country (2025-2030)
10.2.1 United States Targeted Delivery Drugs Market Forecast
10.2.2 Canada Targeted Delivery Drugs Market Forecast
10.2.3 Mexico Targeted Delivery Drugs Market Forecast
10.2.4 Brazil Targeted Delivery Drugs Market Forecast
10.3 APAC Targeted Delivery Drugs Forecast by Region (2025-2030)
10.3.1 China Targeted Delivery Drugs Market Forecast
10.3.2 Japan Targeted Delivery Drugs Market Forecast
10.3.3 Korea Targeted Delivery Drugs Market Forecast
10.3.4 Southeast Asia Targeted Delivery Drugs Market Forecast
10.3.5 India Targeted Delivery Drugs Market Forecast
10.3.6 Australia Targeted Delivery Drugs Market Forecast
10.4 Europe Targeted Delivery Drugs Forecast by Country (2025-2030)
10.4.1 Germany Targeted Delivery Drugs Market Forecast
10.4.2 France Targeted Delivery Drugs Market Forecast
10.4.3 UK Targeted Delivery Drugs Market Forecast
10.4.4 Italy Targeted Delivery Drugs Market Forecast
10.4.5 Russia Targeted Delivery Drugs Market Forecast
10.5 Middle East & Africa Targeted Delivery Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Targeted Delivery Drugs Market Forecast
10.5.2 South Africa Targeted Delivery Drugs Market Forecast
10.5.3 Israel Targeted Delivery Drugs Market Forecast
10.5.4 Turkey Targeted Delivery Drugs Market Forecast
10.5.5 GCC Countries Targeted Delivery Drugs Market Forecast
10.6 Global Targeted Delivery Drugs Forecast by Type (2025-2030)
10.7 Global Targeted Delivery Drugs Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Adverum
11.1.1 Adverum Company Information
11.1.2 Adverum Targeted Delivery Drugs Product Offered
11.1.3 Adverum Targeted Delivery Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Adverum Main Business Overview
11.1.5 Adverum Latest Developments
11.2 Arrowhead Pharmaceuticals
11.2.1 Arrowhead Pharmaceuticals Company Information
11.2.2 Arrowhead Pharmaceuticals Targeted Delivery Drugs Product Offered
11.2.3 Arrowhead Pharmaceuticals Targeted Delivery Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Arrowhead Pharmaceuticals Main Business Overview
11.2.5 Arrowhead Pharmaceuticals Latest Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Targeted Delivery Drugs Product Offered
11.3.3 Bayer Targeted Delivery Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer Latest Developments
11.4 Windtree Therapeutics
11.4.1 Windtree Therapeutics Company Information
11.4.2 Windtree Therapeutics Targeted Delivery Drugs Product Offered
11.4.3 Windtree Therapeutics Targeted Delivery Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Windtree Therapeutics Main Business Overview
11.4.5 Windtree Therapeutics Latest Developments
11.5 Immunocore
11.5.1 Immunocore Company Information
11.5.2 Immunocore Targeted Delivery Drugs Product Offered
11.5.3 Immunocore Targeted Delivery Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Immunocore Main Business Overview
11.5.5 Immunocore Latest Developments
11.6 Mankind Pharma
11.6.1 Mankind Pharma Company Information
11.6.2 Mankind Pharma Targeted Delivery Drugs Product Offered
11.6.3 Mankind Pharma Targeted Delivery Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Mankind Pharma Main Business Overview
11.6.5 Mankind Pharma Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Targeted Delivery Drugs Product Offered
11.7.3 Roche Targeted Delivery Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 Ra Pharma
11.8.1 Ra Pharma Company Information
11.8.2 Ra Pharma Targeted Delivery Drugs Product Offered
11.8.3 Ra Pharma Targeted Delivery Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Ra Pharma Main Business Overview
11.8.5 Ra Pharma Latest Developments
11.9 Keystone Nano
11.9.1 Keystone Nano Company Information
11.9.2 Keystone Nano Targeted Delivery Drugs Product Offered
11.9.3 Keystone Nano Targeted Delivery Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Keystone Nano Main Business Overview
11.9.5 Keystone Nano Latest Developments
11.10 Lipocine
11.10.1 Lipocine Company Information
11.10.2 Lipocine Targeted Delivery Drugs Product Offered
11.10.3 Lipocine Targeted Delivery Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Lipocine Main Business Overview
11.10.5 Lipocine Latest Developments
11.11 MultiVir
11.11.1 MultiVir Company Information
11.11.2 MultiVir Targeted Delivery Drugs Product Offered
11.11.3 MultiVir Targeted Delivery Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 MultiVir Main Business Overview
11.11.5 MultiVir Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂